These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

409 related items for PubMed ID: 11030149

  • 61. Resistance to TRAIL-induced apoptosis in neuroblastoma cells correlates with a loss of caspase-8 expression.
    Eggert A, Grotzer MA, Zuzak TJ, Wiewrodt BR, Ikegaki N, Brodeur GM.
    Med Pediatr Oncol; 2000 Dec; 35(6):603-7. PubMed ID: 11107127
    [Abstract] [Full Text] [Related]

  • 62. Apoptosis induction in renal cell carcinoma by TRAIL and gamma-radiation is impaired by deficient caspase-9 cleavage.
    Ramp U, Caliskan E, Mahotka C, Krieg A, Heikaus S, Gabbert HE, Gerharz CD.
    Br J Cancer; 2003 Jun 02; 88(11):1800-7. PubMed ID: 12771998
    [Abstract] [Full Text] [Related]

  • 63. Prostate-apoptosis-response-gene-4 increases sensitivity to TRAIL-induced apoptosis.
    Boehrer S, Nowak D, Puccetti E, Ruthardt M, Sattler N, Trepohl B, Schneider B, Hoelzer D, Mitrou PS, Chow KU.
    Leuk Res; 2006 May 02; 30(5):597-605. PubMed ID: 16513168
    [Abstract] [Full Text] [Related]

  • 64. Contribution of epigenetic silencing of tumor necrosis factor-related apoptosis inducing ligand receptor 1 (DR4) to TRAIL resistance and ovarian cancer.
    Horak P, Pils D, Haller G, Pribill I, Roessler M, Tomek S, Horvat R, Zeillinger R, Zielinski C, Krainer M.
    Mol Cancer Res; 2005 Jun 02; 3(6):335-43. PubMed ID: 15972852
    [Abstract] [Full Text] [Related]

  • 65. Hypermethylation of the death-associated protein kinase promoter attenuates the sensitivity to TRAIL-induced apoptosis in human non-small cell lung cancer cells.
    Tang X, Wu W, Sun SY, Wistuba II, Hong WK, Mao L.
    Mol Cancer Res; 2004 Dec 02; 2(12):685-91. PubMed ID: 15634757
    [Abstract] [Full Text] [Related]

  • 66. Role of antiapoptotic proteins in tumor necrosis factor-related apoptosis-inducing ligand and cisplatin-augmented apoptosis.
    Kim JH, Ajaz M, Lokshin A, Lee YJ.
    Clin Cancer Res; 2003 Aug 01; 9(8):3134-41. PubMed ID: 12912965
    [Abstract] [Full Text] [Related]

  • 67. Sensitization to TRAIL-induced apoptosis and modulation of FLICE-inhibitory protein in B chronic lymphocytic leukemia by actinomycin D.
    Olsson A, Diaz T, Aguilar-Santelises M, Osterborg A, Celsing F, Jondal M, Osorio LM.
    Leukemia; 2001 Dec 01; 15(12):1868-77. PubMed ID: 11753607
    [Abstract] [Full Text] [Related]

  • 68. Combined inhibition of DNA methyltransferase and histone deacetylase restores caspase-8 expression and sensitizes SCLC cells to TRAIL.
    Kaminskyy VO, Surova OV, Vaculova A, Zhivotovsky B.
    Carcinogenesis; 2011 Oct 01; 32(10):1450-8. PubMed ID: 21771726
    [Abstract] [Full Text] [Related]

  • 69. Fanconi anemia type C-deficient hematopoietic cells are resistant to TRAIL (TNF-related apoptosis-inducing ligand)-induced cleavage of pro-caspase-8.
    Platzbecker U, Kurre P, Guardiola P, Ward JL, Radich JP, Kiem HP, Deeg HJ.
    Exp Hematol; 2004 Sep 01; 32(9):815-21. PubMed ID: 15345282
    [Abstract] [Full Text] [Related]

  • 70. Resistance of human melanoma cells against the death ligand TRAIL is reversed by ultraviolet-B radiation via downregulation of FLIP.
    Zeise E, Weichenthal M, Schwarz T, Kulms D.
    J Invest Dermatol; 2004 Oct 01; 123(4):746-54. PubMed ID: 15373780
    [Abstract] [Full Text] [Related]

  • 71. Constitutively active Akt1 protects HL60 leukemia cells from TRAIL-induced apoptosis through a mechanism involving NF-kappaB activation and cFLIP(L) up-regulation.
    Bortul R, Tazzari PL, Cappellini A, Tabellini G, Billi AM, Bareggi R, Manzoli L, Cocco L, Martelli AM.
    Leukemia; 2003 Feb 01; 17(2):379-89. PubMed ID: 12592338
    [Abstract] [Full Text] [Related]

  • 72. Differential modulation of the TRAIL receptors and the CD95 receptor in colon carcinoma cell lines.
    van Geelen CM, de Vries EG, Le TK, van Weeghel RP, de Jong S.
    Br J Cancer; 2003 Jul 21; 89(2):363-73. PubMed ID: 12865931
    [Abstract] [Full Text] [Related]

  • 73. Sensitization of human colon cancer cells to TRAIL-mediated apoptosis.
    Hernandez A, Wang QD, Schwartz SA, Evers BM.
    J Gastrointest Surg; 2001 Jul 21; 5(1):56-65. PubMed ID: 11309649
    [Abstract] [Full Text] [Related]

  • 74. Epigenetic silencing of death receptor 4 mediates tumor necrosis factor-related apoptosis-inducing ligand resistance in gliomas.
    Elias A, Siegelin MD, Steinmüller A, von Deimling A, Lass U, Korn B, Mueller W.
    Clin Cancer Res; 2009 Sep 01; 15(17):5457-65. PubMed ID: 19706813
    [Abstract] [Full Text] [Related]

  • 75. Reversal of methylation silencing of Apo2L/TRAIL receptor 1 (DR4) expression overcomes resistance of SK-MEL-3 and SK-MEL-28 melanoma cells to interferons (IFNs) or Apo2L/TRAIL.
    Bae SI, Cheriyath V, Jacobs BS, Reu FJ, Borden EC.
    Oncogene; 2008 Jan 17; 27(4):490-8. PubMed ID: 17653094
    [Abstract] [Full Text] [Related]

  • 76. Downmodulation of dimethyl transferase activity enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in prostate cancer cells.
    Festuccia C, Gravina GL, D'Alessandro AM, Millimaggi D, Di Rocco C, Dolo V, Ricevuto E, Vicentini C, Bologna M.
    Int J Oncol; 2008 Aug 17; 33(2):381-8. PubMed ID: 18636160
    [Abstract] [Full Text] [Related]

  • 77. In vitro susceptibility to TRAIL-induced apoptosis of acute leukemia cells in the context of TRAIL receptor gene expression and constitutive NF-kappa B activity.
    Wuchter C, Krappmann D, Cai Z, Ruppert V, Scheidereit C, Dörken B, Ludwig WD, Karawajew L.
    Leukemia; 2001 Jun 17; 15(6):921-8. PubMed ID: 11417478
    [Abstract] [Full Text] [Related]

  • 78. Sensitization for death receptor- or drug-induced apoptosis by re-expression of caspase-8 through demethylation or gene transfer.
    Fulda S, Küfer MU, Meyer E, van Valen F, Dockhorn-Dworniczak B, Debatin KM.
    Oncogene; 2001 Sep 13; 20(41):5865-77. PubMed ID: 11593392
    [Abstract] [Full Text] [Related]

  • 79. Resistance and susceptibility of human uveal melanoma cells to TRAIL-induced apoptosis.
    Li H, Niederkorn JY, Neelam S, Alizadeh H.
    Arch Ophthalmol; 2005 May 13; 123(5):654-61. PubMed ID: 15883285
    [Abstract] [Full Text] [Related]

  • 80. Resistance of human ovarian cancer cells to tumor necrosis factor alpha is a consequence of nuclear factor kappaB-mediated induction of Fas-associated death domain-like interleukin-1beta-converting enzyme-like inhibitory protein.
    Xiao CW, Yan X, Li Y, Reddy SA, Tsang BK.
    Endocrinology; 2003 Feb 13; 144(2):623-30. PubMed ID: 12538625
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.